this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance
BIO News


Sunday, November 22, 2009

Milestones 2004

Click here for a printer-friendly page Printer Friendly
Milestones2004

Table of Contents >

BOARD OF DIRECTORS 2004

David W. Anstice
President Human Health
Merck & Co., Inc.

Lee Babbis
Vice President, Preclinical R&D
Hoffmann-LaRoche Inc.

Frank Baldino, Jr., Ph.D.
Chairman & CEO
Cephalon, Inc.

Andrew Baum
President and CEO
SemBioSys Genetics Inc.

Ernesto Bertarelli
Chief Executive Officer
Serono International SA

Simon G. Best
Chief Executive Officer
Ardana Bioscience Ltd.

Joshua Boger, Ph.D.
Chairman and CEO
Vertex Pharmaceuticals Incorporated

Bruce L. A. Carter, Ph.D.
President and CEO
ZymoGenetics, Inc.

Nancy T. Chang, Ph.D.
President and CEO
Tanox, Inc.

Robert Chess
Chairman
Nektar Therapeutics

C. Boyd Clarke
President and CEO
Neose Technologies, Inc.

Douglas A. Doerfler
President and CEO
MaxCyte, Inc.

Elliot Entis
Chief Executive Officer
A/F Protein, Inc.

Dennis M. Fenton, Ph.D.
Executive Vice President
Amgen

J. Erik Fyrwald
Group Vice President
DuPont Agriculture & Nutrition

Hugh Grant
President and CEO
Monsanto

Richard Hamilton
President and CEO
Ceres, Inc.

W. Scott Harkonen, M.D.
Chairman and CEO
CoTherix, Inc.

William A. Haseltine, Ph.D.
Chairman and CEO
Human Genome Sciences, Inc.

Susan Desmond-Hellmann, M.D., M.P.H.
Executive Vice President, Development and Product Operations, and Chief Medical Officer
Genentech, Inc.

Russell J. Howard, Ph.D.
Chief Executive Officer
Maxygen, Inc.

Louis G. Lange, M.D., Ph.D.
Chairman and CEO
CV Therapeutics, Inc.

Edward Lanphier
President and CEO
Sangamo BioSciences, Inc.

John C. Martin, Ph.D.
President and CEO
Gilead Sciences, Inc.

Jennie Mather
Founder, President and CEO Raven biotechnologies, inc.

Steven J. Mento, Ph.D.
President and CEO
Idun Pharmaceuticals

David M. Mott
CEO and Vice Chairman
MedImmune, Inc.

James C. Mullen
President and CEO
Biogen Idec

H. Stewart Parker
President and CEO
Targeted Genetics Corporation

Richard F. Pops
CEO
Alkermes, Inc.

Hollings C. Renton
Chairman and CEO
Onyx Pharmaceuticals, Inc.

Norbert G. Riedel, Ph.D.
Corporate Vice President and Chief Scientific Officer
Baxter International, Inc.

David E. Robinson
Chairman, President and CEO
Ligand Pharmaceuticals, Inc.

Duane J. Roth
Chairman and CEO
Alliance Pharmaceutical Corp.

Robert R. Ruffolo, Jr.
President, R&D Development
Wyeth Pharmaceuticals

Una S. Ryan, Ph.D.
President and CEO
AVANT Immunotherapeutics, Inc.

Mitchel Sayare, Ph.D.
Chairman and CEO
ImmunoGen, Inc.

Leonard S. Schleifer, M.D., Ph.D.
President and CEO
Regeneron Pharmaceuticals, Inc.

Joseph C. Scodari
Company Group Chairman, Biopharmaceuticals
Johnson & Johnson

Stephen A. Sherwin, M.D.
Chairman and CEO
Cell Genesys, Inc.

W. Pete Siggelko
Vice President, Plant Genetics & Biotechnology
Dow AgroSciences

Mark Skaletsky
Chairman and CEO
Trine Pharmaceutical

Frederick W. Telling, Ph.D.
Vice President, Corporate Policy & Strategic Management
Pfizer Inc.

Henri A. Termeer
Chairman and CEO
Genzyme Corporation

Thomas G. Wiggans
President and CEO
Connetics Corporation

contact us | terms of use | privacy policy
© 2009 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024